Keywords:
C-reactive protein; NMR spectroscopy; SARS-CoV-2; SPC; Supramolecular Phospholipid Composite signals; acute inflammation; blood plasma metabolic phenotyping; cardiovascular disease risk; chronic inflammation; diabetes; glycoproteins; inflammation.
Abstract:
Understanding the distribution and variation in NMR-based inflammatory markers is crucial to the evaluation of their clinical utility in disease prognosis and diagnosis. We applied high-resolution 1H NMR spectroscopy of blood plasma and serum to measure the acute phase reactive glycoprotein signals and the subregions of the lipoprotein-based Supramolecular Phospholipid Composite signals in a large multicohort population study.